Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
. It may aim to level the playing field with one competitor in particular: Amazon.
LVMH shares fell 3.7% after it announced that sales at its core division fell for the first time since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The International Energy Agency predicts demand for fossil fuels will ebb pretty quickly as we move into the second half of the decade.
Google is revamping its shopping service into a more Instagram-slash-TikTok-esque feed, showing users an infinite scroll of products.
Bausch + Lomb has stirred up significant interest from the pair of private equity giants, TPG and Blackstone.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Boeing announced 17,000 layoffs, a delay to the launch of its 777X passenger jet, and billions in charges related to ongoing strikes.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.